AGIOS PHARMACEUTICALS, INC. 10-Q filing
Filed 2025-07-31 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001439222-25-000089
- Form type
- 10-Q
- CIK
- 0001439222
- Primary document
- https://www.sec.gov/Archives/edgar/data/1439222/000143922225000089/agio-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AGIOS PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $21.2M | - | - |
| Cost Of Revenue | $2.8M | - | - |
| Operating Income | $-233.7M | - | - |
| Net Income | $-201.3M | - | - |
| Eps Basic | -3.49 | - | - |
| Eps Diluted | -3.49 | - | - |
| Cash And Equivalents | $80.9M | - | - |
| Total Assets | $1.5B | - | - |
| Total Liabilities | $101.7M | - | - |
| Shareholders Equity | $1.4B | - | - |
| Operating Cash Flow | $-188.6M | - | - |
| Capital Expenditures | $1.6M | - | - |